Publications by authors named "Robert F Manges"

Claim this Profile
S
Safety and efficacy of durvalumab with R-CHOP or R-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial.
Grzegorz S Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas S Larsen, Krish Patel, Robert F Manges

Int J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
Peter M Voorhees, Robert F Manges, Pieter Sonneveld, Sundar Jagannath, George Somlo

Br J Haematol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis